0CONNEXION
Page précédente

Service client 01 53 21 81 51

Leading Players of the Global Medtech Industry

LES POINTS FORTS DE L'ÉTUDE :
  • The medium-term and mega trends of the industry market developments and geographical segments
  • The competitive landscape and the main corporate rankings
  • The main conclusions of our report, summarised in 10 analytical slides
INFORMATIONS ETUDE

Parue le 18/03/2019 -

70 pages

Réf : 9XEEE12 / GLO

1 200 € HT

    COMMANDER

1Présentation
2Plan de l'étude
3Liste des sociétés
PictoXerfi Global


SUR LE MÊME THEME

The Global Medtech Industry: the market

18/03/2019 |  124 Pages1600€

Le marché du diagnostic in vitro à l'horizon 2022

31/07/2018 |  233 Pages1800€

Les laboratoires pharmaceutiques

23/07/2018 |  347 Pages1300€

Le marché du diabète à l'horizon 2020

08/03/2017 |  221 Pages1800€

1 Présentation de l'étude

Exclusive extracts from this 70-page-long report:

- Who are the key players?

The industry is dominated by a handful of large, deep-pocketed companies which compete against a myriad of small-scale, specialised players. Medtech leaders come from diverse backgrounds. Pure players are mainly positioned in markets that require highly specialised medical expertise (wound care, diabetes, cardiovascular, etc.). They compete with the likes of Roche and Abbott, which also operate in the pharmaceutical market, as well as diversified groups (Siemens and GE), which are particularly strong in imaging systems and IT services.

Groups analysed in this report include: Medtronic, Johnson & Johnson – Medical Devices, Koninklijke Philips (Royal Philips), GE Healthcare, Abbott Diagnostics, Cardiovascular & Neuromodulation, Siemens Healthineers, Becton, Dickinson & Co, Stryker Corporation, Roche Diagnostics and Olympus Medical.

- What are the players' strategies?

Broad in scope, the medical device industry is subject to constant technological and scientific progress. The industry is being reshaped by data analytics and artificial intelligence, which are the source of new value-added, end-to-end offerings. The number of new devices marketed has been on the rise, as has the complexity of the approval process, which has become lengthier and costlier. These factors, along with customer pressure to reduce healthcare costs, has enhanced consolidation: niche players are being acquired by large companies, while a few large players have coalesced their operations.

- What are the players' key growth and profitability drivers?

The aggregate revenues of the top 10 medtech firms analysed in this report have risen at a yearly pace of 7.6% over the past five years. This was overwhelmingly driven by inorganic activity. Excluding M&A activity, revenue growth would have been lacklustre. Nonetheless, companies such as Stryker and Medtronic are among the companies that have also reported positive organic revenue performance.

2 Plan de l'étude

1. Overview

1.1. The Sector

1.2. Ranking

1.3. Performance analysis

2. Company Profiles

3. Sources

4. Annexes

3Liste des sociétés

Medtronic,

Johnson & Johnson – Medical Devices,

Koninklijke Philips (Royal Philips),

GE Healthcare,

Abbott Diagnostics,

Cardiovascular & Neuromodulation,

Siemens Healthineers,

Becton,

Dickinson & Co,

Stryker Corporation,

Roche Diagnostics

Olympus Medical

    COMMANDER

PictoXerfi Global

What is the collection Xerfi Global ?

  • Reports cover market fundamentals, the market environment and prospect, corporates strategies and competition
  • Over 60 global markets and competition reports
  • Over 600 companies profiles

The reports provide :

- Decision-makers with analyses and forecasts on the major sectors of the world economy

- Alerts concerning world forecasts and major sectorial or business developments

- Key information on commodities, exchange rates and country performance


PictoDocumentation PDFPictoAjouter à ma wishlist

SUR LE MÊME THÈME

The Global Medtech Industry: the market

18/03/2019 |  124 Pages1600€

Le marché du diagnostic in vitro à l'horizon 2022

31/07/2018 |  233 Pages1800€

Les laboratoires pharmaceutiques

23/07/2018 |  347 Pages1300€

Le marché du diabète à l'horizon 2020

08/03/2017 |  221 Pages1800€

Information

x
Cloud

Cette étude a été ajoutée à votre wishlist d’études, disponible dans votre espace « Mon compte ».

Information

x
Cette étude a bien été supprimée de votre wishlist d’études.

COMMANDER

x
Caddie 0

L'étude a bien été ajoutée
au panier.

Voir mon panier et acheter > Je poursuis ma recherche

En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des contenus adaptés à vos centres d’intérêts et nous permettre de réaliser des statistiques de visites.

En poursuivant votre navigation, vous acceptez l’utilisation de cookies.

J’accepte En savoir +